Terms: = Leukemia AND ATRX, P46100, ZNF-HX, XNP, XH2, SHS, SFM1, RAD54, MRXHF1, MGC2094, ATR2, 546 AND Prognosis
17 results:
1. [Analysis of the clinical characteristics of acute myeloid leukemia related to the treatment of hematological and solid tumors].
Jiao Y; Jiang YH; Liu B; Mi RH; Bi LJ; Xu QX
Zhonghua Zhong Liu Za Zhi; 2024 Jan; 46(1):86-95. PubMed ID: 38246784
[No Abstract] [Full Text] [Related]
2. Comparison of the 2022 and 2017 European leukemiaNet risk classifications in a real-life cohort of the PETHEMA group.
Sargas C; Ayala R; Larráyoz MJ; Chillón MC; Rodriguez-Arboli E; Bilbao C; Prados de la Torre E; Martínez-Cuadrón D; Rodríguez-Veiga R; Boluda B; Gil C; Bernal T; Bergua J; Algarra L; Tormo M; Martínez-Sánchez P; Soria E; Serrano J; Alonso-Dominguez JM; García R; Amigo ML; Herrera-Puente P; Sayas MJ; Lavilla-Rubira E; Martínez-López J; Calasanz MJ; García-Sanz R; Pérez-Simón JA; Gómez Casares MT; Sánchez-García J; Barragán E; Montesinos P;
Blood Cancer J; 2023 May; 13(1):77. PubMed ID: 37173322
[TBL] [Abstract] [Full Text] [Related]
3. Factors associated with risk and prognosis of intensive care unit admission in patients with acute leukemia: a Danish nationwide cohort study.
Maeng CV; Christiansen CF; Liu KD; Kamper P; Christensen S; Medeiros BC; Østgård LSG
Leuk Lymphoma; 2022 Oct; 63(10):2290-2300. PubMed ID: 35583300
[TBL] [Abstract] [Full Text] [Related]
4. Assessment of Patient-Specific Human Leukocyte Antigen Genomic Loss at Relapse After Antithymocyte Globulin-Based T-Cell-Replete Haploidentical Hematopoietic Stem Cell Transplant.
Wu H; Shi J; Luo Y; Yu J; Lai X; Liu L; Fu H; Ouyang G; Xu X; Xiao H; Huang H; Zhao Y
JAMA Netw Open; 2022 Apr; 5(4):e226114. PubMed ID: 35385089
[TBL] [Abstract] [Full Text] [Related]
5. Incidence of Acute Myeloid leukemia and Myelodysplastic Syndrome in Patients With Inflammatory Bowel Disease and the Impact of Thiopurines on Their Risk.
Khan N; Patel D; Trivedi C; Kavani H; Pernes T; Medvedeva E; Lewis J; Xie D; Yang YX
Am J Gastroenterol; 2021 Apr; 116(4):741-747. PubMed ID: 33982944
[TBL] [Abstract] [Full Text] [Related]
6. [The Relationship between ASXL2 and ZBTB7A Gene Mutations and prognosis in Patients with Acute Myeloid leukemia].
Cao HQ; Tuo JB
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Apr; 29(2):450-455. PubMed ID: 33812414
[TBL] [Abstract] [Full Text] [Related]
7. Secondhand smoke: A new and modifiable prognostic factor in childhood acute lymphoblastic leukemias.
Cárceles-Álvarez A; Ortega-García JA; López-Hernández FA; Fuster-Soler JL; Ramis R; Kloosterman N; Castillo L; Sánchez-Solís M; Claudio L; Ferris-Tortajada J
Environ Res; 2019 Nov; 178():108689. PubMed ID: 31479979
[TBL] [Abstract] [Full Text] [Related]
8. Synthetic lethality of cytolytic HSV-1 in cancer cells with atrx and PML deficiency.
Han M; Napier CE; Frölich S; Teber E; Wong T; Noble JR; Choi EHY; Everett RD; Cesare AJ; Reddel RR
J Cell Sci; 2019 Mar; 132(5):. PubMed ID: 30745338
[TBL] [Abstract] [Full Text] [Related]
9. Clinical Features and prognosis According to Immunophenotypic Subtypes Including the Early T-Cell Precursor Subtype of T-Lymphoblastic Lymphoma in the Japanese Pediatric leukemia/Lymphoma Study Group ALB-NHL03 Study.
Fukano R; Sunami S; Sekimizu M; Takimoto T; Mori T; Mitsui T; Mori T; Saito AM; Watanabe T; Ohshima K; Fujimoto J; Nakazawa A; Kiyokawa N; Kobayashi R; Horibe K; Tsurusawa M
J Pediatr Hematol Oncol; 2018 Jan; 40(1):e34-e37. PubMed ID: 28538509
[TBL] [Abstract] [Full Text] [Related]
10. Phase 2, randomized, double-blind study of pracinostat in combination with azacitidine in patients with untreated, higher-risk myelodysplastic syndromes.
Garcia-Manero G; Montalban-Bravo G; Berdeja JG; Abaza Y; Jabbour E; Essell J; Lyons RM; Ravandi F; Maris M; Heller B; DeZern AE; Babu S; Wright D; Anz B; Boccia R; Komrokji RS; Kuriakose P; Reeves J; Sekeres MA; Kantarjian HM; Ghalie R; Roboz GJ
Cancer; 2017 May; 123(6):994-1002. PubMed ID: 28094841
[TBL] [Abstract] [Full Text] [Related]
11. Independent prognostic impact of CD15 on complete remission achievement in patients with acute myeloid leukemia.
Chisini M; Stefanizzi C; Ceglie T; Raponi S; Vozella F; Colafigli G; Salaroli A; D'Angiò M; Mancini M; Diverio D; Breccia M; Mancini F; Minotti C; Trisolini S; Capria S; Testi AM; Guarini A; Latagliata R; De Propris MS; Foà R
Hematol Oncol; 2017 Dec; 35(4):804-809. PubMed ID: 27400753
[TBL] [Abstract] [Full Text] [Related]
12. Loss of DAXX and atrx are associated with chromosome instability and reduced survival of patients with pancreatic neuroendocrine tumors.
Marinoni I; Kurrer AS; Vassella E; Dettmer M; Rudolph T; Banz V; Hunger F; Pasquinelli S; Speel EJ; Perren A
Gastroenterology; 2014 Feb; 146(2):453-60.e5. PubMed ID: 24148618
[TBL] [Abstract] [Full Text] [Related]
13. [Clinical analysis on adult acute T-lymphoblastic leukemia].
Zhang Q; Zhou CL; Fu MW; Wang JY; Lin D; Liu BC; Li W; Mi YC; Wang JX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Apr; 20(2):478-82. PubMed ID: 22541122
[TBL] [Abstract] [Full Text] [Related]
14. Expression level of lipoprotein lipase in Chinese patients with chronic lymphocytic leukemia and its correlation with other prognostic factors.
Xu W; Li JY; Shen QD; Wu YJ; Yu H; Fan L
Int J Lab Hematol; 2009 Oct; 31(5):552-9. PubMed ID: 18616755
[TBL] [Abstract] [Full Text] [Related]
15. Acute myeloid leukemia subgroups identified by pathway-restricted gene expression signatures.
Serrano E; Lasa A; Perea G; Carnicer MJ; Brunet S; Aventín A; Sierra J; Nomdedéu JF
Acta Haematol; 2006; 116(2):77-89. PubMed ID: 16914901
[TBL] [Abstract] [Full Text] [Related]
16. Persistence of lymphoblasts in bone marrow on day 15 and days 22 to 25 of remission induction predicts a dismal treatment outcome in children with acute lymphoblastic leukemia.
Sandlund JT; Harrison PL; Rivera G; Behm FG; Head D; Boyett J; Rubnitz JE; Gajjar A; Raimondi S; Ribeiro R; Hudson M; Relling M; Evans W; Pui CH
Blood; 2002 Jul; 100(1):43-7. PubMed ID: 12070006
[TBL] [Abstract] [Full Text] [Related]
17. High glucocorticoid receptor content of leukemic blasts is a favorable prognostic factor in childhood acute lymphoblastic leukemia.
Kato GJ; Quddus FF; Shuster JJ; Boyett J; Pullen JD; Borowitz MJ; Whitehead VM; Crist WM; Leventhal BG
Blood; 1993 Oct; 82(8):2304-9. PubMed ID: 8400283
[TBL] [Abstract] [Full Text] [Related]
